These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 16857959)

  • 21. Coronary vasomotor and blood flow responses to isoflavone-intact soya protein in subjects with coronary heart disease or risk factors for coronary heart disease.
    Webb CM; Hayward CS; Mason MJ; Ilsley CD; Collins P
    Clin Sci (Lond); 2008 Dec; 115(12):353-9. PubMed ID: 18442357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WHI and WHIMS follow-up and human studies of soy isoflavones on cognition.
    Zhao L; Brinton RD
    Expert Rev Neurother; 2007 Nov; 7(11):1549-64. PubMed ID: 17997703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soy consumption, adhesion molecules, and pro-inflammatory cytokines: a brief review of the literature.
    Beavers KM; Jonnalagadda SS; Messina MJ
    Nutr Rev; 2009 Apr; 67(4):213-21. PubMed ID: 19335715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.
    Buse JB; Ginsberg HN; Bakris GL; Clark NG; Costa F; Eckel R; Fonseca V; Gerstein HC; Grundy S; Nesto RW; Pignone MP; Plutzky J; Porte D; Redberg R; Stitzel KF; Stone NJ; ;
    Diabetes Care; 2007 Jan; 30(1):162-72. PubMed ID: 17192355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Isoflavones--an update on scientific data].
    Döll M
    Med Monatsschr Pharm; 2008 Jan; 31(1):11-7. PubMed ID: 18522015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soy protein and cardiovascular disease: the impact of bioactive components in soy.
    Potter SM
    Nutr Rev; 1998 Aug; 56(8):231-5. PubMed ID: 9735676
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association.
    Marwick TH; Hordern MD; Miller T; Chyun DA; Bertoni AG; Blumenthal RS; Philippides G; Rocchini A; ; ; ; ;
    Circulation; 2009 Jun; 119(25):3244-62. PubMed ID: 19506108
    [No Abstract]   [Full Text] [Related]  

  • 28. Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial.
    Ho SC; Chen YM; Ho SS; Woo JL
    Menopause; 2007; 14(5):905-12. PubMed ID: 17413839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Worksite wellness programs for cardiovascular disease prevention: a policy statement from the American Heart Association.
    Carnethon M; Whitsel LP; Franklin BA; Kris-Etherton P; Milani R; Pratt CA; Wagner GR; ; ; ;
    Circulation; 2009 Oct; 120(17):1725-41. PubMed ID: 19794121
    [No Abstract]   [Full Text] [Related]  

  • 30. Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association.
    Krauss RM; Eckel RH; Howard B; Appel LJ; Daniels SR; Deckelbaum RJ; Erdman JW; Kris-Etherton P; Goldberg IJ; Kotchen TA; Lichtenstein AH; Mitch WE; Mullis R; Robinson K; Wylie-Rosett J; St Jeor S; Suttie J; Tribble DL; Bazzarre TL
    J Nutr; 2001 Jan; 131(1):132-46. PubMed ID: 11208950
    [No Abstract]   [Full Text] [Related]  

  • 31. Isoflavone-poor soy protein alters the lipid metabolism of rats by SREBP-mediated down-regulation of hepatic genes.
    Shukla A; Brandsch C; Bettzieche A; Hirche F; Stangl GI; Eder K
    J Nutr Biochem; 2007 May; 18(5):313-21. PubMed ID: 16962760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional foods for cardiovascular disease in women.
    Rudkowska I
    Menopause Int; 2008 Jun; 14(2):63-9. PubMed ID: 18519267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing.
    Vetter VL; Elia J; Erickson C; Berger S; Blum N; Uzark K; Webb CL; ;
    Circulation; 2008 May; 117(18):2407-23. PubMed ID: 18427125
    [No Abstract]   [Full Text] [Related]  

  • 34. Noninherited risk factors and congenital cardiovascular defects: current knowledge.
    Pediatrics; 2007 Aug; 120(2):445-6. PubMed ID: 17671072
    [No Abstract]   [Full Text] [Related]  

  • 35. Isoflavones, substances with multi-biological and clinical properties.
    Ren MQ; Kuhn G; Wegner J; Chen J
    Eur J Nutr; 2001 Aug; 40(4):135-46. PubMed ID: 11905954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of isoflavones in the cholesterol reduction by soy proteins in the clinic.
    Sirtori CR; Gianazza E; Manzoni C; Lovati MR; Murphy PA
    Am J Clin Nutr; 1997 Jan; 65(1):166-7. PubMed ID: 8988932
    [No Abstract]   [Full Text] [Related]  

  • 37. ACCF/AHA/ACP 2009 competence and training statement: a curriculum on prevention of cardiovascular disease: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease): developed in collaboration with the American Academy of Neurology; American Association of Cardiovascular and Pulmonary Rehabilitation; American College of Preventive Medicine; American College of Sports Medicine; American Diabetes Association; American Society of Hypertension; Association of Black Cardiologists; Centers for Disease Control and Prevention; National Heart, Lung, and Blood Institute; National Lipid Association; and Preventive Cardiovascular Nurses Association.
    Bairey Merz CN; Alberts MJ; Balady GJ; Ballantyne CM; Berra K; Black HR; Blumenthal RS; Davidson MH; Fazio SB; Ferdinand KC; Fine LJ; Fonseca V; Franklin BA; McBride PE; Mensah GA; Merli GJ; O'Gara PT; Thompson PD; Underberg JA; ; ; ; ; ; ; ; ; ; ;
    Circulation; 2009 Sep; 120(13):e100-26. PubMed ID: 19770387
    [No Abstract]   [Full Text] [Related]  

  • 38. Reduced mammary tumor progression in a transgenic mouse model fed an isoflavone-poor soy protein concentrate.
    Chiesa G; Rigamonti E; Lovati MR; Disconzi E; Soldati S; Sacco MG; Catò EM; Patton V; Scanziani E; Vezzoni P; Arnoldi A; Locati D; Sirtori CR
    Mol Nutr Food Res; 2008 Oct; 52(10):1121-9. PubMed ID: 18655005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
    Grundy SM; Benjamin IJ; Burke GL; Chait A; Eckel RH; Howard BV; Mitch W; Smith SC; Sowers JR
    Circulation; 1999 Sep; 100(10):1134-46. PubMed ID: 10477542
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics.
    Kavey RE; Allada V; Daniels SR; Hayman LL; McCrindle BW; Newburger JW; Parekh RS; Steinberger J; ; ; ; ; ; ; ;
    Circulation; 2006 Dec; 114(24):2710-38. PubMed ID: 17130340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.